0.00
price down icon100.00%   -129.46
after-market Dopo l'orario di chiusura: 129.50 129.50 +
loading

Perché le azioni Blueprint Medicines Corp (BPMC) sono in ribasso?

2023-08-02:

Shares of Blueprint Medicines (BPMC) were down more than 15.34% to $54.30 on Wednesday after the healthcare company announced second-quarter earnings. While the numbers were generally positive, investors are likely to sell on good news, taking advantage of a positive announcement, but the selling got out of hand.

https://www.fool.com/investing/2023/08/02/why-shares-of-blueprint-medicines-are-falling-wedn/

$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Capitalizzazione:     |  Volume (24 ore):